Psoriasis is a relatively common skin disease that most people have heard of but in reality it is more than that. The problem begins beneath the skin and appears on the outer layer of epidermis. It is a chronic immune system deficiency that presents with red, blotchy patches on various parts of skin. There have been many attempts to beat this condition but few have ever been as successful as this new study.
About 80 percent of patients with moderate to severe psoriasis saw their disease completely or almost completely cleared with a new drug called ixekizumab, according to three large, long-term clinical trials.